Network News

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

HI-TAC: Karina Yaniv Appointed as New Scientific Director

Helmholtz Institute for Translational AngioCardioScience brings together expertise in cardiac, vascular and systems biology Prof. Dr Karina Yaniv of the Weizmann Institute of Science has been appointed as new Scientific Director of the Helmholtz Institute for Translational AngioCardioScience in Mannheim/Heidelberg (HI-TAC), the Max Delbrück Center in Berlin and Heidelberg University announced in cooperation with the […]

Unlocking the Lung’s Ability to Heal

NK Cell Immunotherapy offers New Hope for Fibrosis Research jointly led by scientists at the Heidelberg site of the German Center for Lung Research and investigators in Boston at Massachusetts General Hospital and Harvard Medical School identifies a new immunotherapy-based approach for lung fibrosis: reactivating natural killer cell (NK cells) to eliminate senescent fibroblasts, reverse […]

New Publication by Yumab: Novel bispecific T-cell engagers overcoming acquired EGFR resistance

In a paper newly published in mAbs, Universität Stuttgart-, Technical University of Braunschweig-, and YUMAB GmbH-based authors reveal research results for novel antagonistic anti-EGFR antibodies that have potential to overcome resistance to current T-cell engagers against the same target. ABSTRACT Epidermal growth factor receptor (EGFR) is a validated therapeutic target in several human cancers harboring […]

ariadne.ai SPATIAL Platform Enables Discovery of Novel Microglial Subpopulation in Human Alzheimer’s Disease Brain

Nature Neuroscience study identifies human plaque-associated microglia using deep learning-based cell segmentation

Providing a cellular ‘all-clear’ signal to resume protein synthesis

Researchers’ newest technologies allow them to discover tiny protein that plays a big role in awakening dormant cells when it’s safe to resume normal operations Summary It’s a tough world for microbes. When resources grow limited and environments worsen, microbes have figured out ways to hunker down and go dormant until conditions improve. However, scientists […]

Scientists uncover thousands of new proteins in ‘dark proteome’

An international consortium has found over 1,700 new proteins from noncoding DNA, many of which show potential as targets for cancer immunotherapy In a collaborative effort, scientists in the TransCODE consortium reveal more than 1,700 new proteins that could have implications for human diseases, including cancer. These tiny proteins were found in what’s called the […]